White matter damage after chronic subclinical inflammation in newborn mice

Xiaoyang Wang1, Gunnel Hellgren, Chatarina Löfqvist

  • 1Perinatal Center, Department of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, S-405 30 Gothenburg, Sweden. xiaoyang.wang@fysiologi.gu.se

Journal of Child Neurology
|September 12, 2009
PubMed

Insights

Chronic inflammation in early life, even at subclinical levels, can impair brain development in preterm infants. This may lead to white matter injury and is linked to lower insulin-like growth factor 1 levels.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Immunology

Background:

  • Preterm infants exposed to inflammation face higher risks of white matter injury and cerebral palsy.
  • Chronic inflammation's impact on developing white matter requires further investigation.

Purpose of the Study:

  • To investigate the effects of chronic low-dose inflammation on developing white matter in a preclinical model.
  • To assess changes in white matter, gray matter volume, and key growth factors.

Main Methods:

  • Administered low-dose lipopolysaccharide (LPS) daily from postnatal days 3-11.
  • Examined white matter integrity using immunohistochemistry for axonal, myelin, and oligodendrocyte markers at postnatal day 12.
  • Measured serum levels of insulin-like growth factor 1 (IGF-1) and insulin-like factor binding protein-3 (IGFBP-3).

Main Results:

  • LPS exposure reduced serum IGF-1 levels but not IGFBP-3.
  • Impaired myelination was observed in the subcortical white matter at postnatal day 12.
  • Decreased brain gray matter volume and increased spleen and liver weights were noted.

Conclusions:

  • Chronic subclinical inflammation negatively impacts white and gray matter development in early life.
  • The observed effects may be associated with a deficiency in insulin-like growth factor 1.
  • Findings highlight the vulnerability of the developing brain to inflammatory insults.

Related Concept Videos